🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨 Exciting News! 🚨 The American Kidney Fund has appointed Dr. Pranav Garimella as its first-ever Chief Medical Officer! 🎉 A transformative step in advancing kidney health and patient care nationwide. 👏 Learn more: kidneyfund.org/article/americ… #KidneyHealth #Leadership

The effects of #plasmaexchange and #glucocorticoids on early kidney function among patients with #ANCA-associated #vasculitis in the PEXIVAS trial doi.org/10.1016/j.kint… #OpenAccess #glomerulonephritis #ESKD

EMPA-KIDNEY expanded the CKD population that may benefit from SGLT2 inhibitors in terms of eGFR and UACR. In patients meeting the enrollment criteria for the EMPA-KIDNEY trial, the addition of empagliflozin to the standard treatment of CKD was as cost-effective for patients with

25 years ago, rare kidney disease (RKD) was a lonely battle fought in the dark. NephCure turned on the light. Starting in 2000, we’ve been the leading voice creating hope for patients navigating RKD. The work isn’t done. But today, we stand 25 years closer to a cure for RKD.

Here comes an all-star review on Treatment of Patients with IgA Nephropathy Juergen Floege Brad H Rovin Jonathan Barratt @ameliebjean kidney-international.org/article/S0085-…

Brendon Neuen and I had such a great time delving into hierarchical composite endpoints with 2 🌎 experts! We 💯 will be seeing more HCEs in future trials so great time to start learning about them 🤓

Pranav Garimella , MBBS, MPH, AKF’s Chief Medical Officer spoke with yanina yaanina last week about the significance of semaglutide’s new indication for patients with type 2 diabetes and chronic kidney disease. Watch the full interview: hcplive.com/view/understan… #Semaglutide #CKD

Classification of ANCA associated vasculitis (AAV) continues to be controversial. In this article, the authors discuss a recent article in The Lancet Rheumatology which proposes a model-based clustering approach for AAV subclassification. bit.ly/KN170124-25

📣REGENCY pub is out!! nejm.org/doi/full/10.10…

Please Join Us for the Inaugural AI Nephrology Symposium! 😊🙏 Inaugural AI Nephrology Symposium, a collaborative event hosted by UAB, UC San Diego, and Mount Sinai, in partnership with ATTIS. This event will take place on April 8-9, 2025, at UAB’s brand-new Altec/Syslinger

During #NationalKidneyMonth, we're uniting patients, families, researchers, and physicians to drive RKD awareness and ensure those at risk or affected by these diseases receive the right education and support. Join us in creating a future without RKD. champ.ly/Ck9z-2sO

Clinical Presentation and Outcomes of #ANCA Negative #Pauciimmune #Glomerulonephritis #VisualAbstract by Pallavi Prasad MD DNB kireports.org/article/S2468-…

Cyclophosphamide - still key for the induction therapy of ANCA vasculitis #ERAMeeting

🧬 😃 invite everyone to join the discussion on the American Society of Nephrology AI Community Forum: “Unraveling the Kidney’s Molecular Puzzle – Multi-Omics Integration in Nephrology.” This discussion highlights how integrating genomics, metabolomics, spatial transcriptomics, and AI is redefining

Cardiovascular involvement in ANCA-associated vasculitis doi.org/10.1093/ndt/gf…

Antineutrophil Cytoplasmic Autoantibodies: Role in... : Journal of the American Society of Nephrology journals.lww.com/jasn/abstract/… Koyal Jain

A nourished child today means a stronger world tomorrow. Let’s commit to prioritising nutrition for every mother, every child, everywhere. UNICEF South Asia

🗞️Virtual Podocyte registration, centers of excellence, clinical trialist incubators and more! Our latest news in your inbox and at eu1.hubs.ly/H0k8dWM0

🔍 AI Agents vs Agentic AI: How Agentic AI is Revolutionizing Kidney Care? 📌 Visit our American Society of Nephrology community forum on AI In the rapidly evolving field of nephrology, clinicians are turning to artificial intelligence (AI) to manage complex workflows and decision-making. But not

Against Bumrah's yorker. In the Qualifier. Shreyas Iyer, you magician 🎩